Loading insider details...
Latest Form 4 (Jun 12, 2026): Exercise/Conversion of 22,515 SNDX shares, $311.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Syndax Pharmaceuticals Inc (SNDX) | Exercise/Conversion | 22,515 | $311.2K |
| Feb 6, 2026 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 24,000 | n/a |
| May 19, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Purchase | 11,765 | $105.8K |